Publicaciones (111) Publicaciones en las que ha participado algún/a investigador/a

2024

  1. A Cross-Sectional Study to Assess the Knowledge of Pharmacy Students About Drug Pollution in Spain

    American Journal of Pharmaceutical Education, Vol. 88, Núm. 9

  2. A disturbed metabolite-GPCR axis is associated with microbial dysbiosis in IBD patients: Potential role of GPR109A in macrophages

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1870, Núm. 8

  3. A miRNA-based epigenetic molecular clock for biological skin-age prediction

    Archives of dermatological research, Vol. 316, Núm. 6, pp. 326

  4. A mild increase in nutrient signaling to mTORC1 in mice leads to parenchymal damage, myeloid inflammation and shortened lifespan

    Nature Aging, Vol. 4, Núm. 8, pp. 1102-1120

  5. Aberrant TIMP-1 production in tumor-associated fibroblasts drives the selective benefits of nintedanib in lung adenocarcinoma

    Cancer Science, Vol. 115, Núm. 5, pp. 1505-1519

  6. Age-related loss of Notch3 underlies brain vascular contractility deficiencies, glymphatic dysfunction, and neurodegeneration in mice

    Journal of Clinical Investigation, Vol. 134, Núm. 2

  7. Alpha-1 antitrypsin deficiency

    Medicina Clinica, Vol. 162, Núm. 7, pp. 336-342

  8. Atezolizumab Plus Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma: Real-life Experience from a Single Tertiary Centre in Spain and ALBI Score as a Survival Prognostic Factor

    Cancer Diagnosis and Prognosis, Vol. 4, Núm. 5, pp. 623-630

  9. Author Correction: Brain areas lipidomics in female transgenic mouse model of Alzheimer's disease (Scientific Reports, (2024), 14, 1, (870), 10.1038/s41598-024-51463-3)

    Scientific Reports

  10. Being fit in the COVID-19 era and future epidemics prevention: Importance of cardiopulmonary exercise test in fitness evaluation

    Progress in Cardiovascular Diseases, Vol. 83, pp. 84-91

  11. Benefits of rilpivirine for liver stiffness in HIV/HCV-coinfected patients

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 42, Núm. 2, pp. 74-79

  12. Beyond Weight Loss: Evaluating Cardiovascular Advantages of GLP-1 Receptor Agonists

    American Journal of Cardiovascular Drugs

  13. Bictegravir alters glucose tolerance in vivo and causes hepatic mitochondrial dysfunction

    Antiviral Research, Vol. 231

  14. Brain areas lipidomics in female transgenic mouse model of Alzheimer's disease

    Scientific Reports, Vol. 14, Núm. 1

  15. COVID-19’s Consequences on the Cardiovascular System: Immediate, Intermediate, and Long-Term Complications

    Elsevier, pp. 1-274

  16. Calorie restriction modulates mitochondrial dynamics and autophagy in leukocytes of patients with obesity

    Free Radical Biology and Medicine, Vol. 225, pp. 677-686

  17. Cardiovascular benefits of SGLT2 inhibitors and GLP-1 receptor agonists through effects on mitochondrial function and oxidative stress

    Free Radical Biology and Medicine, Vol. 213, pp. 19-35

  18. Cardiovascular comorbidities and COVID-19 outcomes

    Covid-19's Consequences on the Cardiovascular System: Immediate, Intermediate, and Long-Term Complications (Elsevier), pp. 19-26

  19. Cerebroprotective Effects of the TLR4-Binding DNA Aptamer ApTOLL in a Rat Model of Ischemic Stroke and Thrombectomy Recanalization

    Pharmaceutics, Vol. 16, Núm. 6

  20. Circadian alignment of food intake and glycaemic control by time-restricted eating: A systematic review and meta-analysis

    Reviews in Endocrine and Metabolic Disorders, Vol. 25, Núm. 2, pp. 325-337